Drug Shortage Report for TOBRADEX
| Report ID | 20969 |
| Drug Identification Number | 00778907 |
| Brand name | TOBRADEX |
| Common or Proper name | TOBRADEX SUSP 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE TOBRAMYCIN |
| Strength(s) | 0.1% 0.3% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01CA |
| ATC description | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2017-08-25 |
| Estimated end date | 2017-09-11 |
| Actual end date | 2017-09-13 |
| Shortage status | Resolved |
| Updated date | 2017-09-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-09-05 | English | Compare |
| v2 | 2017-09-05 | French | Compare |
| v3 | 2017-09-13 | English | Compare |
| v4 | 2017-09-13 | French | Compare |
| v5 | 2017-09-14 | English | Compare |
Showing 1 to 5 of 5